posted on 2023-03-31, 18:46authored bySubrata Manna, Josefine Bostner, Yang Sun, Lance D. Miller, Anya Alayev, Naomi S. Schwartz, Elin Lager, Tommy Fornander, Bo Nordenskjöld, Jane J. Yu, Olle Stål, Marina K. Holz
Supplementary figure 1: Validation of the ERRα antibody used for immunohistochemical analysis; Supplementary Figure 2: The prognostic value of ERRα protein expression and subcellular location in adjuvant-untreated ER-negative patients; Supplementary Figure 3: ERRα protein expression is not prognostic in ER-positive breast cancer.
Funding
NIH
American Cancer Society
National Cancer Center, and funding from Yeshiva University and the Swedish Cancer Society